SEC Form 3 · accession 0001469709-17-000122
REJUVEL BIO-SCIENCES, INC. · NUUU
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Joseph Pavlik
Officer — CEO · Director
Period of report
Jan 19, 2017
Accepted (ET)
Jun 8, 2017 · 4:29 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001481427
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| SERIES A PREFERRED | holding | — | — | — | 1,500,000 | D | ||
| SERIES C PREFERRED | holding | — | — | — | 7,000,000 | D |
Table II — derivative securities
No Table II lines on this filing.